Interventional Oncology Market By Product (Embolization Devices, Ablation Devices, and Support Devices), By Cancer Type (Kidney, Lung, Breast, Liver, Bone Metastasis, and Others), and By Procedure (Thermal Ablation, Non-Thermal Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization, and Transcatheter Arterial Embolization)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report analyzes and forecasts the interventional oncology market on a global and regional level. The study offers past data from 2017 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The assessment of interventional oncology market dynamics gives a brief thought about the drivers and restraints of the interventional oncology market along with their impact on the demand over the years to come. Additionally, the report also includes the study of opportunities available in the interventional oncology market on a global level.

The report gives a transparent view of the interventional oncology market. We have included a detailed competitive scenario and portfolio of the leading vendors operating in the interventional oncology market. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces Model for the interventional oncology market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The interventional oncology market is fragmented on the basis of product, cancer type, procedure, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players involved in the interventional oncology market are Boston Scientific, Terumo Corporation, Medtronic, BTG, Ethicon, AngioDynamics, Merit Medical Systems, Sirtex Medical, Eckert & Ziegler, BEBIG, Siemens Healthineers, Varian Medical Systems, and HealthTronics.

This report segments the global interventional oncology market into:

Global Interventional Oncology Market: Product Analysis

	Embolization Devices


	Radioembolic Agents
	Non-Radioactive Agents


	Ablation Devices


	Radiofrequency Ablation Devices
	Microwave Ablation Devices
	Cryoablation Devices
	Others


	Support Devices


	Guidewires
	Microcatheter

Global Interventional Oncology Market: Cancer Type Analysis

	Kidney Cancer
	Lung Cancer
	Breast Cancer
	Liver Cancer
	Bone Metastasis Cancer
	Others

Global Interventional Oncology Market: Procedure Analysis

	Thermal Tumor Ablation
	Non-Thermal Tumor Ablation
	Transcatheter Arterial Chemoembolization
	Transcatheter Arterial Radioembolization
	Transcatheter Arterial Embolization

Global Interventional Oncology Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa